Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Cash flows from operating activities:
Net loss	$ (2,370,629)	$ (2,560,094)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	8,350	19,801
Stock-based compensation expense	327,500	469,724
Changes in assets and liabilities:
Grant funds and other receivables	53,211	(62,056)
Prepaid expenses and other current assets	(56,211)	36,480
Accounts payable and accrued expenses	639,282	553,119
Total adjustments	972,132	1,017,068
Net cash used in operating activities	(1,398,497)	(1,543,026)
Cash flows from investing activities:
Purchase of property and equipment	(7,606)
Net cash used in investing activities	(7,606)
Cash flows from financing activities:
Net proceeds from sale of preferred stock	1,440,000	1,190,000
Proceeds from issuance of notes payable		300,000
Principal repayment of notes payable	(10,257)
Net cash provided by financing activities	1,429,743	1,490,000
Net increase (decrease) in cash and cash equivalents	23,640	(53,026)
Cash and cash equivalents at beginning of period	259,701	312,727
Cash and cash equivalents at end of period	$ 283,341	$ 259,701